Save 10% off on your first order with coupon code: PANDA10

Health & Wellness Blog

13Feb, 2026

Mounjaro Dosage: Complete 2.5mg→15mg Titration Chart + Missed Dose Protocol

February 13, 2026|

Mounjaro (tirzepatide) is an FDA-approved once-weekly injectable medicine manufactured by Eli Lilly for adults and children aged 10 years and older with type 2 diabetes. The active ingredient tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist that helps lower blood sugar levels and promotes weight loss when used alongside [...]

13Feb, 2026

GLP-1 Supplements 2026: Best Natural OTC That Actually Boost GLP-1 Levels

February 13, 2026|

GLP-1 supplements are natural dietary products that claim to increase your body's production of glucagon-like peptide-1 (GLP-1) a crucial hormone that regulates appetite and blood sugar.  Unlike prescription medications like semaglutide (Ozempic, Wegovy) that inject synthetic GLP-1 mimics directly into your body, these supplements use plant-derived compounds like berberine, curcumin, resveratrol and bitter melon to [...]

13Feb, 2026

Rybelsus vs Jardiance: Complete Type 2 Diabetes Comparison Guide

February 13, 2026|

Rybelsus and Jardiance represent two leading oral medication options for managing blood glucose levels in adults with type 2 diabetes. Both drugs are FDA-approved to improve glycemic control when combined with diet and exercise, yet they work through fundamentally different mechanisms and offer distinct clinical advantages. According to the PIONEER 2 clinical trial, Rybelsus 14mg [...]

13Feb, 2026

GLP-1 Microdosing: Microdose Chart, Schedule + Side Effects Guide

February 13, 2026|

GLP-1 microdosing is an emerging practice where individuals take sub-therapeutic doses of GLP-1 medications typically 0.05 to 0.25mg of semaglutide weekly versus the standard 0.25 to 2.4mg to minimize side effects while achieving gradual weight loss and metabolic benefits.  According to research published in Diabetes Care, microdosing offers a tailored solution to maximize therapeutic benefit, [...]

13Feb, 2026

GLP-1 Patches 2026: Do They Work? Kind Patches, Gentle, Patched Reviews + Side Effects

February 13, 2026|

No, GLP-1 patches do not work as advertised. According to the FDA, there are no FDA-approved GLP-1 patches, and if you can buy a product without a prescription, it is not an actual GLP-1 drug.  GLP-1 patches marketed on social media and online retailers are over-the-counter adhesive skin patches that claim to support weight loss [...]

11Feb, 2026

Does Trulicity Cause Weight Loss? 4-7% Clinical Results + Realistic Expectations

February 11, 2026|

Yes, Trulicity (dulaglutide) does cause weight loss in most patients, producing a modest 4-7% body weight reduction in type 2 diabetes patients through GLP-1 mediated appetite suppression and slowing digestion. Trulicity is a once-weekly injectable medication belonging to the GLP-1 receptor agonists class. It works by mimicking the natural GLP-1 hormone, which stimulates the pancreas [...]

20Feb, 2026

Trulicity Coupon 2026: $25 Savings Card, Copay, Discounts Guide

February 20, 2026|

As of early 2026, the average retail price of Trulicity without insurance is approximately $1,395.75 for four Trulicity pens a standard 30-day supply. The good news: several savings programs exist to help eligible patients dramatically reduce what they pay out [...]

17Feb, 2026

Zepbound Insurance Coverage: Complete Guide to Prior Authorization & Approval

February 17, 2026|

Zepbound insurance coverage stands at approximately 45% for commercial plans requiring BMI ≥30 or ≥27 with comorbidities, while Medicare excludes weight-loss indications entirely. Employer-sponsored plans show 55% approval rates after prior authorization. Roughly 97 million Americans are in plans that [...]

13Feb, 2026

Mounjaro Dosage: Complete 2.5mg→15mg Titration Chart + Missed Dose Protocol

February 13, 2026|

Mounjaro (tirzepatide) is an FDA-approved once-weekly injectable medicine manufactured by Eli Lilly for adults and children aged 10 years and older with type 2 diabetes. The active ingredient tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) [...]

6Feb, 2026

Does Mounjaro Make You Tired? 8-12% Fatigue Rate + Evidence-Based Recovery

February 6, 2026|

Mounjaro (tirzepatide) is an FDA-approved medication to treat type 2 diabetes and support weight loss by mimicking two naturally occurring hormones: glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. These hormones work by enhancing insulin secretion, reducing appetite, slowing gastric emptying, and [...]

5Feb, 2026

Trulicity vs Wegovy: Wegovy 15% Weight Loss vs Trulicity 7 lbs – Diabetes vs Obesity Drugs

February 5, 2026|

Wegovy delivers approximately 15% body weight loss in clinical trials-dramatically outperforming Trulicity’s average weight reduction of about 7–10 lbs (3–5% of body weight). Both are GLP-1 receptor agonists administered as once-weekly injections, yet Wegovy produces roughly 2.5 times greater weight [...]

1Sep, 2025

Ozempic vs Insulin

September 1, 2025|

Effective blood glucose management is a critical need for many. Ozempic and insulin are two commonly used diabetes medications. While both address diabetes, they function differently. Ozempic is a prescription medication for adults with type 2 diabetes. Interestingly, it also [...]

4Aug, 2025

Is Compounded Mounjaro Safe? Understanding Tirzepatide Compounding for Informed Choices

August 4, 2025|

Tirzepatide is a prescription drug that has been gaining popularity. Millions are exploring it for weight management and diabetes. But sometimes, the exact medication isn't readily available. This leads to "compounding."  What are Compounded Drugs? Compounded versions of medications are [...]

3Jun, 2025

Does Ozempic Cause Hair Loss?

June 3, 2025|

You've scrolled through social media, seen the news, and maybe even heard friends talking about Ozempic and its remarkable weight loss results. It's become a household name, but with its growing popularity comes a wave of questions, especially regarding potential [...]

Go to Top
X